Brenda M. Calderon

516 total citations
10 papers, 195 citations indexed

About

Brenda M. Calderon is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Brenda M. Calderon has authored 10 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in Brenda M. Calderon's work include RNA regulation and disease (3 papers), RNA Research and Splicing (3 papers) and interferon and immune responses (2 papers). Brenda M. Calderon is often cited by papers focused on RNA regulation and disease (3 papers), RNA Research and Splicing (3 papers) and interferon and immune responses (2 papers). Brenda M. Calderon collaborates with scholars based in United States, Spain and Uganda. Brenda M. Calderon's co-authors include Graeme L. Conn, Juan J. de la Cruz, Pedro de la Oliva, Ana Gómez-Zamora, Juan José Menéndez Suso, Cristina Schüffelmann, Ketaki Ganti, Anjelica L. Gonzalez, Yi Zhang and John Steel and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The FASEB Journal.

In The Last Decade

Brenda M. Calderon

8 papers receiving 195 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brenda M. Calderon United States	6	69	66	54	42	33	10	195
Nonantzin Beristain‐Covarrubias United Kingdom	6	29 0.4×	7 0.1×	68 1.3×	41 1.0×	16 0.5×	9	219
S Weimann Austria	9	166 2.4×	9 0.1×	168 3.1×	7 0.2×	98 3.0×	21	390
Jason Girkin Australia	10	63 0.9×	46 0.7×	179 3.3×	1 0.0×	74 2.2×	14	352
Maki Murata Japan	6	24 0.3×	9 0.1×	40 0.7×	4 0.1×	41 1.2×	13	163
Grace Thompson Australia	8	22 0.3×	6 0.1×	65 1.2×	2 0.0×	25 0.8×	19	196
Hiromi Nagashima Japan	8	27 0.4×	15 0.2×	25 0.5×		62 1.9×	31	252
Ling Sun China	7	55 0.8×	14 0.2×	49 0.9×		97 2.9×	14	232
Yukiko Hiraguchi Japan	10	26 0.4×	20 0.3×	76 1.4×		57 1.7×	26	366
Susanne Schubert Germany	5	66 1.0×	34 0.5×	31 0.6×		238 7.2×	11	306
Zaisheng Zhu China	5	40 0.6×	38 0.6×	145 2.7×		86 2.6×	11	328

Countries citing papers authored by Brenda M. Calderon

Since Specialization

Citations

This map shows the geographic impact of Brenda M. Calderon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda M. Calderon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda M. Calderon more than expected).

Fields of papers citing papers by Brenda M. Calderon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brenda M. Calderon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda M. Calderon. The network helps show where Brenda M. Calderon may publish in the future.

Co-authorship network of co-authors of Brenda M. Calderon

This figure shows the co-authorship network connecting the top 25 collaborators of Brenda M. Calderon. A scholar is included among the top collaborators of Brenda M. Calderon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda M. Calderon. Brenda M. Calderon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Hatta, Masato, Yasuko Hatta, Wei Wang, et al.. (2025). ACE2 Receptor Usage across Animal Species by SARS-CoV-2 Variants. Emerging infectious diseases. 31(8). 1640–1644.

Calderon, Brenda M., Xiaoyu Fan, Yunrong Gao, et al.. (2023). Structural basis of the American mink ACE2 binding by Y453F trimeric spike glycoproteins of SARS‐CoV‐2. Journal of Medical Virology. 95(10). e29163–e29163.

Han, Patrick, Sean Bickerton, Jung Seok Lee, et al.. (2021). Direct Comparison of B Cell Surface Receptors as Therapeutic Targets for Nanoparticle Delivery of BTK Inhibitors. Molecular Pharmaceutics. 18(3). 850–861. 2 indexed citations

Calderon, Brenda M., Shamika Danzy, Nathan T. Jacobs, et al.. (2019). Dysregulation of M segment gene expression contributes to influenza A virus host restriction. PLoS Pathogens. 15(8). e1007892–e1007892. 20 indexed citations

Calderon, Brenda M. & Graeme L. Conn. (2018). A human cellular noncoding RNA activates the antiviral protein 2′–5′-oligoadenylate synthetase 1. Journal of Biological Chemistry. 293(41). 16115–16124. 19 indexed citations

Sauler, Maor, Yue Hou, Jonathan Merola, et al.. (2018). Endothelial cell‐secreted MIF reduces pericyte contractility and enhances neutrophil extravasation. The FASEB Journal. 33(2). 2171–2186. 28 indexed citations

Calderon, Brenda M. & Graeme L. Conn. (2017). Human noncoding RNA 886 (nc886) adopts two structurally distinct conformers that are functionally opposing regulators of PKR. RNA. 23(4). 557–566. 29 indexed citations

Suso, Juan José Menéndez, Brenda M. Calderon, Ana Gómez-Zamora, et al.. (2016). Incidence and risk factors of superficial and deep vein thrombosis associated with peripherally inserted central catheters in children. Journal of Thrombosis and Haemostasis. 14(11). 2158–2168. 77 indexed citations

Calderon, Brenda M., et al.. (2014). A novel RNA molecular signature for activation of 2′-5′ oligoadenylate synthetase-1. Nucleic Acids Research. 43(1). 544–552. 19 indexed citations

10.

Calderon, Brenda M., et al.. (1982). [Serological evaluation of polyvalent A-C anti-meningococcal vaccine in Chile].. PubMed. 93(2). 149–57. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact